This study provides insights about the Tumor Ablation Market in regards to its uses and benefits. We at Crystal Market Research (CMR) provide updated information that is beneficial in decision making regarding business investments.
The Tumor Ablation Market was worth USD 0.28 billion in 2014 and is expected to reach approximately USD 0.86 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.15% during the forecast period.
Explore Report Description with Detailed TOC on Tumor Ablation Market at: www.crystalmarketresearch.com/report/tumor-ablation-market .
Industry Outlook and Trend Analysis:
Expanding pervasiveness of cancer is the main consideration contributing for the development of the market. On the basis of the insights published by World Health Organization (WHO), around 13% of the general population suffer from cancer around the world. Furthermore, there is 70.0% ascent in cancer cases expected throughout the following couple of decades. Hence, in excess of 100 cancer composes need tumour ablation in this manner boosting market development over the conjecture time frame. Technological progressions in the field of thermal ablation technologies are expected to fuel market development. The fast ascent in maturing populace is anticipated to increase.
Major Leading Players:
The leading players in the market are AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc. These industry players have implemented different methodologies to support their position in the market. For example, collaborations, new product launches, mergers and acquisitions, technological advancements are the most well-known activities in this industry.
Regional Outlook and Trend Analysis:
North America ruled the general tumor ablation market with more than 32.0% share in 2015. Main factors adding to development of this district incorporate support of the government for quality healthcare, availability of reimbursement, high purchasing power parity, and expanding predominance of growths in the U.S. also, Canada. In expansion, accuracy prescription activity is detailing the custom fitted procedures on exceptional qualities of diseases.
Technology Outlook and Trend Analysis:
Radiofrequency tumor ablation technology held considerable share in 2015. Radiofrequency ablation uses of imaging devices and needle electrode probe to pierce through skin. High recurrence currents are gone through electrode for creating heat in order to decimate tumor cells. These electric currents create sound waves; these waves at that point produce warm responding target cell particle. Increasing application of this innovation in solid tumor removal everywhere throughout the body and its specificity contributed its development.
Get Premium Sample Copy at: www.crystalmarketresearch.com/report-sample/HC06854 .
Treatment Outlook and Trend Analysis:
Surgical ablation fragment held significant share of 42.1% of every 2015. Expanded pervasiveness of cancers such as liver disease and breast cancer, which require open surgical methods, added to development of surgical procedures. Nonetheless, percutaneous procedures are anticipated to reflect lucrative development over the estimate time frame. Rising interest for minimally invasive surgeries is high-affect rendering factor adding to their development. These methods offer quicker recovery, diminished scarring, and expanded security.
Application Outlook and Trend Analysis:
Liver cancer represented biggest shares in 2015. Liver cancer is most common in males as opposed to females, and rising rate of bile duct cancer and also primary liver cancer brought about their dominion. Lung cancer has been expected to develop with the most astounding CAGR amid the conjecture time frame. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC).
The Tumor Ablation Market is segmented as follows-
By Technology: Microwave ablation, Cryoablation, Radiofrequency ablation and Other ablation technologies
By Treatment: Surgical tumor ablation, Laparoscopic tumor ablation and Percutaneous tumor ablation
By Application: Liver cancer, Breast cancer, Lung cancer, Prostate cancer and Other cancers
By Region: North America: (U.S., Canada & Mexico), Europe: (Germany, UK, France, Russia, Italy & Rest of Europe), Asia-Pacific: (China, Japan, South Korea, India, Southeast Asia & Rest of Asia-Pacific), South America: (Brazil, Argentina, Columbia, South Africa & Rest of South America) and Middle East and Africa: (Saudi Arabia, UAE, Egypt, Nigeria, South Africa & Rest of MEA)
Ask Questions to Expertise at:
www.crystalmarketresearch.com/send-an-enquiry/HC06854 .
Major ToC of Tumor Ablation Market:
Part 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Part 2. Executive Summary
2.1. Key Highlights
Part 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
Part 4. Market Analysis by Regions4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2014-2023)
4.1.2. Canada Market States and Outlook (2014-2023)
4.1.3. Mexico Market States and Outlook (2014-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2014-2023)
4.2.2. France Market States and Outlook (2014-2023)
4.2.3. UK Market States and Outlook (2014-2023)
4.2.4. Russia Market States and Outlook (2014-2023)
4.2.5. Italy Market States and Outlook (2014-2023)
4.2.6. Rest of Europe Market States and Outlook (2014-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2014-2023)
4.3.2. Japan Market States and Outlook (2014-2023)
4.3.3. Korea Market States and Outlook (2014-2023)
4.3.4. India Market States and Outlook (2014-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2014-2023)
4.4.2. Argentina Market States and Outlook (2014-2023)
4.4.3. Columbia Market States and Outlook (2014-2023)
4.4.4. Rest of South America Market States and Outlook (2014-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2014-2023)
4.5.2. UAE Market States and Outlook (2014-2023)
4.5.3. Egypt Market States and Outlook (2014-2023)
4.5.4. Nigeria Market States and Outlook (2014-2023)
4.5.5. South Africa Market States and Outlook (2014-2023)
4.5.6. Rest of MEA Market States and Outlook (2014-2023)
Part 5. Tumor Ablation Market, By Technology
5.1. Introduction
5.2. Global Tumor Ablation Sales, Revenue and Market Share by Technology (2014-2018)
5.2.1. Global Tumor Ablation Sales and Sales Share by Technology (2014-2018)
5.2.2. Global Tumor Ablation Revenue and Revenue Share by Technology (2014-2018)
5.3. Radiofrequency
5.3.1. Global Radiofrequency Sales and Growth Rate (2014-2018)
5.4. Microwave ablation
5.4.1. Global Microwave ablation Sales and Growth Rate (2014-2018)
5.5. Cryoablation
5.5.1. Global Cryoablation Sales and Growth Rate (2014-2018)
5.6. Other ablation technologies
5.6.1. Global Other ablation technologies Sales and Growth Rate (2014-2018)
...CONTINUED FOR TOC
(Early buyers will receive 10% customization on this report.)
Get Amazing Discount on Report at: www.crystalmarketresearch.com/check-discount/HC06854 .
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Crystal Market Research
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
The Tumor Ablation Market was worth USD 0.28 billion in 2014 and is expected to reach approximately USD 0.86 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.15% during the forecast period.
Explore Report Description with Detailed TOC on Tumor Ablation Market at: www.crystalmarketresearch.com/report/tumor-ablation-market .
Industry Outlook and Trend Analysis:
Expanding pervasiveness of cancer is the main consideration contributing for the development of the market. On the basis of the insights published by World Health Organization (WHO), around 13% of the general population suffer from cancer around the world. Furthermore, there is 70.0% ascent in cancer cases expected throughout the following couple of decades. Hence, in excess of 100 cancer composes need tumour ablation in this manner boosting market development over the conjecture time frame. Technological progressions in the field of thermal ablation technologies are expected to fuel market development. The fast ascent in maturing populace is anticipated to increase.
Major Leading Players:
The leading players in the market are AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc. These industry players have implemented different methodologies to support their position in the market. For example, collaborations, new product launches, mergers and acquisitions, technological advancements are the most well-known activities in this industry.
Regional Outlook and Trend Analysis:
North America ruled the general tumor ablation market with more than 32.0% share in 2015. Main factors adding to development of this district incorporate support of the government for quality healthcare, availability of reimbursement, high purchasing power parity, and expanding predominance of growths in the U.S. also, Canada. In expansion, accuracy prescription activity is detailing the custom fitted procedures on exceptional qualities of diseases.
Technology Outlook and Trend Analysis:
Radiofrequency tumor ablation technology held considerable share in 2015. Radiofrequency ablation uses of imaging devices and needle electrode probe to pierce through skin. High recurrence currents are gone through electrode for creating heat in order to decimate tumor cells. These electric currents create sound waves; these waves at that point produce warm responding target cell particle. Increasing application of this innovation in solid tumor removal everywhere throughout the body and its specificity contributed its development.
Get Premium Sample Copy at: www.crystalmarketresearch.com/report-sample/HC06854 .
Treatment Outlook and Trend Analysis:
Surgical ablation fragment held significant share of 42.1% of every 2015. Expanded pervasiveness of cancers such as liver disease and breast cancer, which require open surgical methods, added to development of surgical procedures. Nonetheless, percutaneous procedures are anticipated to reflect lucrative development over the estimate time frame. Rising interest for minimally invasive surgeries is high-affect rendering factor adding to their development. These methods offer quicker recovery, diminished scarring, and expanded security.
Application Outlook and Trend Analysis:
Liver cancer represented biggest shares in 2015. Liver cancer is most common in males as opposed to females, and rising rate of bile duct cancer and also primary liver cancer brought about their dominion. Lung cancer has been expected to develop with the most astounding CAGR amid the conjecture time frame. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC).
The Tumor Ablation Market is segmented as follows-
By Technology: Microwave ablation, Cryoablation, Radiofrequency ablation and Other ablation technologies
By Treatment: Surgical tumor ablation, Laparoscopic tumor ablation and Percutaneous tumor ablation
By Application: Liver cancer, Breast cancer, Lung cancer, Prostate cancer and Other cancers
By Region: North America: (U.S., Canada & Mexico), Europe: (Germany, UK, France, Russia, Italy & Rest of Europe), Asia-Pacific: (China, Japan, South Korea, India, Southeast Asia & Rest of Asia-Pacific), South America: (Brazil, Argentina, Columbia, South Africa & Rest of South America) and Middle East and Africa: (Saudi Arabia, UAE, Egypt, Nigeria, South Africa & Rest of MEA)
Ask Questions to Expertise at:
www.crystalmarketresearch.com/send-an-enquiry/HC06854 .
Major ToC of Tumor Ablation Market:
Part 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Part 2. Executive Summary
2.1. Key Highlights
Part 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
Part 4. Market Analysis by Regions4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2014-2023)
4.1.2. Canada Market States and Outlook (2014-2023)
4.1.3. Mexico Market States and Outlook (2014-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2014-2023)
4.2.2. France Market States and Outlook (2014-2023)
4.2.3. UK Market States and Outlook (2014-2023)
4.2.4. Russia Market States and Outlook (2014-2023)
4.2.5. Italy Market States and Outlook (2014-2023)
4.2.6. Rest of Europe Market States and Outlook (2014-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2014-2023)
4.3.2. Japan Market States and Outlook (2014-2023)
4.3.3. Korea Market States and Outlook (2014-2023)
4.3.4. India Market States and Outlook (2014-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2014-2023)
4.4.2. Argentina Market States and Outlook (2014-2023)
4.4.3. Columbia Market States and Outlook (2014-2023)
4.4.4. Rest of South America Market States and Outlook (2014-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2014-2023)
4.5.2. UAE Market States and Outlook (2014-2023)
4.5.3. Egypt Market States and Outlook (2014-2023)
4.5.4. Nigeria Market States and Outlook (2014-2023)
4.5.5. South Africa Market States and Outlook (2014-2023)
4.5.6. Rest of MEA Market States and Outlook (2014-2023)
Part 5. Tumor Ablation Market, By Technology
5.1. Introduction
5.2. Global Tumor Ablation Sales, Revenue and Market Share by Technology (2014-2018)
5.2.1. Global Tumor Ablation Sales and Sales Share by Technology (2014-2018)
5.2.2. Global Tumor Ablation Revenue and Revenue Share by Technology (2014-2018)
5.3. Radiofrequency
5.3.1. Global Radiofrequency Sales and Growth Rate (2014-2018)
5.4. Microwave ablation
5.4.1. Global Microwave ablation Sales and Growth Rate (2014-2018)
5.5. Cryoablation
5.5.1. Global Cryoablation Sales and Growth Rate (2014-2018)
5.6. Other ablation technologies
5.6.1. Global Other ablation technologies Sales and Growth Rate (2014-2018)
...CONTINUED FOR TOC
(Early buyers will receive 10% customization on this report.)
Get Amazing Discount on Report at: www.crystalmarketresearch.com/check-discount/HC06854 .
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
Crystal Market Research
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
No comments:
Post a Comment